the bioanalysis market | France

1.1 Definition and scope of the study

Bioanalysis consists of analyze biomolecules to identify, quantify and characterize them in order to obtain marketing authorization for a product .

The origin of bioanalysis in pharmacy comes from the emergence in Europe of drugs manufactured with biotechnologies and corresponding to the label " Products produced by recombinant DNA techniques "of the European Pharmacopoeia. The methods of analysis of biomolecules are clearly different from those of the classical analysis of relatively small organic compounds. This has given rise to a new branch of analysis: bioanalysis.

The bioanalysis market affects three sectors: health, agri-food and the environment . In reality, this is analytical subcontracting for pharmaceutical laboratories, cosmetics manufacturers, food companies, etc.

This market is seen as a rather dynamic market and while its CAGR over the period 2012-2019 was in double digits, this remained positive despite the health crisis. Since 2020, the Covid-19 crisis offers precisely new growth prospects for this market due to increased risk, consumer distrust of their food and pharmaceutical products that is constantly increasing

This dynamism is mainly based on a limited number of companies that are leaders in their field: Eurofins Scientific is even the world leader in the sector. Eurofins Scientific, as well as other companies such as Phytocontrol and Carso, continue to expand internationally through new laboratories and external growth operations aimed at strengthening the expertise already possessed by these companies or, on the contrary, helping them to develop a more complete and differentiated offer